Patents by Inventor Richard Earl Higgs, Jr.

Richard Earl Higgs, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230220062
    Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
    Type: Application
    Filed: January 25, 2023
    Publication date: July 13, 2023
    Inventors: Richard Earl HIGGS, Jr., Robert John KONRAD, Brian Jeffrey NICKOLOFF, Robert William SIEGEL, II
  • Patent number: 11591387
    Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: February 28, 2023
    Assignee: Eli Lilly and Company
    Inventors: Richard Earl Higgs, Jr., Robert John Konrad, Brian Jeffrey Nickoloff, Robert William Siegel, II
  • Publication number: 20200354444
    Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
    Type: Application
    Filed: June 17, 2020
    Publication date: November 12, 2020
    Inventors: Richard Earl Higgs, JR., Robert John Konrad, Brian Jeffrey Nickoloff, Robert William Siegel, II
  • Patent number: 6021213
    Abstract: An automatic contextual segmentation method which can be used to identify features in QCT images of femora, tibiae and vertebrae. The principal advantages of this automatic approach over traditional techniques such as histomorphometry are, 1) the algorithms can be implemented in a fast, uniform, non-subjective manner across many images allowing unbiased comparisons of therapeutic efficacy, 2) much larger volumes in the region of interest can be analyzed, and 3) QCT can be used longitudinally. Two automatic contextual segmentation algorithms relate to a cortical bone algorithm (CBA) and a whole bone algorithm (WBA). These methods include a preprocessing step, a threshold selection step, a segmentation step satisfying logical constraints, a pixel wise label image updating step, and a feature extraction step; with the WBA including whole bone segmentation, cortical segmentation, spine segmentation, and centrum segmentation.
    Type: Grant
    Filed: June 13, 1996
    Date of Patent: February 1, 2000
    Assignee: Eli Lilly and Company
    Inventors: Jeffrey Donald Helterbrand, Richard Earl Higgs, Jr., Philip Wayne Iversen